{"id":60754,"date":"2017-11-06T09:39:36","date_gmt":"2017-11-06T14:39:36","guid":{"rendered":"http:\/\/www.hedgeco.net\/news\/?p=60754"},"modified":"2017-11-06T09:39:36","modified_gmt":"2017-11-06T14:39:36","slug":"ainsling-capital-raises-280m-for-latest-life-sciences-fund","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/11\/2017\/ainsling-capital-raises-280m-for-latest-life-sciences-fund.html","title":{"rendered":"Ainsling Capital Raises $280M For Latest Life Sciences Fund"},"content":{"rendered":"<p>(FINalternatives) New York-based life sciences private equity company Aisling Capital has raised $280 million capital commitments for its latest fund to focus on bringing breakthrough medical treatments to market.<\/p>\n<p><a href=\"http:\/\/finalternatives.com\/node\/36130\">To read this article:<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(FINalternatives) New York-based life sciences private equity company Aisling Capital has raised $280 million capital commitments for its latest fund to focus on bringing breakthrough medical treatments to market. To read this article:<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-60754","post","type-post","status-publish","format-standard","hentry","category-syndicated"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/60754","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=60754"}],"version-history":[{"count":1,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/60754\/revisions"}],"predecessor-version":[{"id":60755,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/60754\/revisions\/60755"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=60754"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=60754"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=60754"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}